CLINICIAN LEAD: 
Jeffrey Bassett, MD, Benjamin & Carmela Du Endowed Chair in Urologic Oncology 

INVESTMENT DATE
Spring 2023

INVESTMENT AMOUNT
$293,000

THE CHALLENGE

According to the American Cancer Society, prostate cancer is the most common cancer in American men other than skin cancer. One man in eight will be diagnosed with prostate cancer during his lifetime, and one man in 41 will die from prostate cancer. Historically, prostate cancer screening tools and practices have been limited, but with recent innovations in tests and detection technologies, there is an opportunity to significantly improve the prostate cancer screening process.

THE INNOVATION

The Prostate Cancer Screening Clinic will bridge the gap between basic screening in a primary care office and advanced screening in a urologic oncology office. A dedicated nurse practitioner will see patients and provide screenings at the clinic using different advanced tools, allowing Hoag’s urologic oncologists to focus on treatment. Working collaboratively with Hoag Medical Group, the Prostate Cancer Screening Clinic will help ensure the right screenings are consistently offered to the right patients. 

THE RESULTS

To date, more than 150 patients have been screened for early prostate cancer using a customized urine test optimized by Hoag urologic oncologists, Dr. Jeffrey Basset and Dr. Robert Torrey. These patients

are being followed in the Prostate Cancer Screening Clinic, and their clinical information has been entered into a comprehensive database that serves as a crucial tool for analyzing test outcomes and guiding patient surveillance and care. Ongoing data analysis and tracking will determine the needs of the Prostate Cancer Screening Clinic going forward, including increased staffing, expansion to additional physician participation, new partnerships, and additional patient screenings.

​

​​Read More Stories